Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs.

Authors
Publication date
1 January 2023
Publisher
'Elsevier BV'
Doi
    View on PubMed

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      UCL Discovery

      redirect
      oaioai:eprints.ucl.ac.uk.OAI2:101...
      Last time updated on 04/05/2023

      PubMed Central

      redirect
      oaioai:pubmedcentral.nih.gov:9813...
      Last time updated on 08/01/2023

      Serveur académique lausannois

      redirect
      oaioai:serval.unil.ch:BIB_B9A4F5D...
      Last time updated on 22/02/2023

      EUR Research Repository

      redirect
      oaioai:pure.eur.nl:publications/4...
      Last time updated on 29/05/2023

      NARCIS

      redirect
      Last time updated on 24/03/2023

      EUR Research Repository

      redirect
      oaioai:pure.eur.nl:openaire_cris_...
      Last time updated on 29/05/2023

      NARCIS

      redirect
      Last time updated on 02/02/2023